Assessment In Response To Ketamine Patients In A Palliative Care Unit
A study examines that to assess the response to ketamine in patients with difficult pain syndromes in a clinical setting of a supportive/palliative care unit (SPCU), where ketamine has been used for years to treat difficult pain conditions and reverse states of hyperexcitation. Ketamine in subanesthetic doses has been found to have analgesic effects. The analgesic effect of ketamine is likely to occur through its antagonism on N-methyl-D-aspartate (NMDA) receptors.